Material Agreements

HASBRO, INC. amended Fourth Amended and Restated Revolving Credit Agreement with Bank of America, N.A. valued at $1,100,000,000 revolving credit facility, with potential incremental increase of $550,000,000 (effective 2026-02-20).

“Item 1.01 Entry into a Material Definitive Agreement. On February 20, 2026 (the "Effective Date"), Hasbro, Inc. (the "Company" or the "Borrower") entered into a Fourth Amended and Restated Revolving Credit Agreement (the "Amended Agreement") with Bank of America, N.A., as administrative agent, swing line lender, L/C issuer and lender, and certain other financial institutions, as L/C issuers and/or lenders.”

FIRST MID BANCSHARES, INC. amended Sixth Amended and Restated Credit Agreement with The Northern Trust Company valued at $15 million revolving loan (effective 2026-02-19).

“On February 19, 2026, First Mid Bancshares, Inc. (the “Company”) entered into a Tenth Amendment (the “Amendment”) to its Sixth Amended and Restated Credit Agreement, dated as of April 12, 2019, as amended, with The Northern Trust Company evidencing a $15 million revolving loan.”

PULTEGROUP INC/MI/ entered into Senior Notes Indenture and Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $800,000,000 senior unsecured notes offering ($400,000,000 4.250% Senior Notes due 2031 and $400,000 (effective 2026-02-20).

“On February 20, 2026, PulteGroup, Inc. (the “ Company ”) completed an underwritten public offering of a total of $800.0 million aggregate principal amount of its senior unsecured notes, consisting of $400.0 million aggregate principal amount of its 4.250% Senior Notes due 2031 (the “ 2031 Notes ”) and $400.0 million aggregate principal amount of its 4.900% Senior Notes due 2036 (the “ 2036 Notes ” and, together with the 2031 Notes, the “ Notes ”), in each case, pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-293234), the prospectus dated February 5, 2026 contained therein, and the related prospectus supplement dated February 10, 2026.”

EASTMAN CHEMICAL CO entered into Indenture with Computershare Trust Company, National Association valued at $600,000,000 aggregate principal amount of 4.500% Notes due 2031 (effective 2026-02-20).

“On February 20, 2026, Eastman Chemical Company (the “Company”) issued $600,000,000 aggregate principal amount of 4.500% Notes due 2031 (the “Notes”) in a public offering (the “Notes Offering”) pursuant to a registration statement on Form S-3 (File No. 333-280083) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the SEC. The Notes were issued under an indenture, dated as of June 5, 2012 (the “Indenture”), by and between the Company and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee (the “Trustee”).”

SOUTHERN CALIFORNIA EDISON Co terminated Prior Term Loan Agreement with Wells Fargo (effective 2026-02-20).

“On February 20, 2026, concurrently with the execution of the Term Loan Agreement described in Item 1.01 above, SCE terminated the Prior Term Loan Agreement, which was due to mature on March 11, 2027.”

SOUTHERN CALIFORNIA EDISON Co entered into Term Loan Agreement with Wells Fargo Bank, National Association, as Administrative Agent, and the several banks and other financial institutions from time to time parties thereto valued at $1.5 billion (effective 2026-02-20).

“On February 20, 2026, Southern California Edison Company (“SCE”) entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) with Wells Fargo Bank, National Association (“Wells Fargo”), as Administrative Agent and the several banks and other financial institutions from time to time parties thereto.”

GABELLI MULTIMEDIA TRUST INC. amended Sales Agreement with G.research, LLC (effective 2026-02-20).

“On February 20, 2026, The Gabelli Multimedia Trust Inc. (NYSE: GGT) (the “Fund”) entered into amendment no. 2 to the sales agreement dated April 16, 2025 (the “Amendment” and the agreement, as so amended, the “Sales Agreement”), between the Fund and G.research, LLC (the “Sales Manager”), pursuant to which the Fund may offer and sell up to 17,000,000 share of common stock of the Fund, par value $0.001 per share (the “Common Stock”), from time to time, through the Sales Manager, in transactions deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Offering”).”

W. P. Carey Inc. entered into Forward Sale Agreements with Bank of America, N.A. and JPMorgan Chase Bank, National Association (effective 2026-02-17).

“In connection with the Offering, the Company also entered into certain forward sale agreements (the “Forward Sale Agreements”) with the Forward Purchasers.”

W. P. Carey Inc. entered into Underwriting Agreement with BofA Securities, Inc., J.P. Morgan Securities LLC, Bank of America, N.A., and JPMorgan Chase Bank, National Association valued at $432 million (effective 2026-02-17).

“On February 17, 2026, W. P. Carey Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc. and J.P. Morgan Securities LLC as underwriters (collectively, the “Underwriters”), BofA Securities, Inc. and J.P. Morgan Securities LLC (in such capacities, the “Forward Sellers”) and Bank of America, N.A. and JPMorgan Chase Bank, National Association (in such capacities, the “Forward Purchasers”) in connection with an underwritten public offering (the “Offering”) of 6,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), at a price per share to the Underwriters of $71.38 (the “Purchase Price”).”

GETTY REALTY CORP /MD/ entered into Forward Sale Agreements with JPMorgan Chase Bank, National Association and Wells Fargo Bank, National Association (effective 2026-02-17).

“Morgan Securities LLC and Wells Fargo Securities, LLC as the underwriters and, as applicable, the forward sellers (together, in such capacities, the “ Underwriters ” and the “ Forward Sellers , ” as applicable) and each of JPMorgan Chase Bank, National Association and Wells Fargo Bank, National Association, as the forward purchasers (together, in such capacity, the “ Forward Purchasers ”), relating to the sale of 4,000,000 shares (the “ Shares ”) of common stock, par value $0.01 per share, of the Company (the “ Common Stock ”) offered by the Forward Sellers in connection with certain forward sale agreements described below, at a price to the Underwriters of $32.48 per share.”

GETTY REALTY CORP /MD/ entered into Underwriting Agreement with J.P. Morgan Securities LLC and Wells Fargo Securities, LLC valued at $32.48 per share (effective 2026-02-17).

“On February 17, 2026, Getty Realty Corp. (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with each of J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as the underwriters”

AppTech Payments Corp. amended First Amendment to Revenue Participation Agreement with Ascendancy Management, Inc. valued at $2,000,000 (effective 2026-02-17).

“On February 17, 2026, AppTech Payments Corp., a Delaware corporation (the “Company”), entered into the First Amendment to Revenue Participation Agreement (the “Amendment”), by and between the Company and Ascendancy Management, Inc. (the “Participant”), amending that certain Revenue Participation Agreement dated as of November 7, 2025 (the “Original Agreement” and as amended by the Amendment, “the Agreement”).”

Opus Genetics, Inc. entered into Registration Rights Agreement with the Purchasers valued at Company will register the resale of shares of Common Stock issuable upon conversion of Series B Pref (effective 2026-02-18).

“In connection with the Private Placement, the Company also entered into a Registration Rights Agreement, dated February 18, 2026 (the “Registration Rights Agreement”), with the Purchasers, which provides that the Company will register the resale of the shares of Common Stock issuable upon conversion of the Series B Preferred Stock.”

Opus Genetics, Inc. entered into Securities Purchase Agreement with certain purchasers valued at Aggregate purchase price of approximately $25.0 million for 7,374,632 shares of Series B Non-Voting (effective 2026-02-13).

“On February 13, 2026, Opus Genetics, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain purchasers (the “Purchasers”) for a private placement (the “Private Placement”) of an aggregate of 7,374,632 shares of its Series B Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”).”

FIRST SOLAR, INC. terminated Existing Credit Agreement with JPMorgan Chase Bank, N.A. valued at Voluntary termination of senior secured revolving credit agreement dated June 30, 2023 (effective 2026-02-13).

“On February 13, 2026, substantially concurrently with the Company’s entry into the Credit Agreement, the Company voluntarily terminated its existing senior secured revolving credit agreement (the “Existing Credit Agreement”), dated as of June 30, 2023 and as amended from time to time, among the Company, the guarantors from time to time party thereto, the several banks and other financial institutions or entities from time to time parties thereto, and JPMorgan Chase Bank, N.A., as administrative agent.”

FIRST SOLAR, INC. entered into Revolving Credit and Guaranty Agreement with JPMorgan Chase Bank, N.A. valued at $1,500,000,000 senior unsecured five-year revolving credit facility with $450,000,000 sub-limit for (effective 2026-02-13).

“On February 13, 2026, First Solar, Inc. (the “Company”) entered into a Revolving Credit and Guaranty Agreement (the “Credit Agreement”), among the Company, the guarantors from time to time party thereto, the several banks and other financial institutions or entities from time to time parties thereto (the “Lenders”), and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”).”

Kentucky First Federal Bancorp terminated Formal Written Agreement dated August 13, 2024 with Office of the Comptroller of the Currency valued at Termination of the Agreement (effective 2026-02-19).

“On February 19, 2026, the Office of the Comptroller of the Currency (the “OCC”), the primary federal banking regulator of First Federal Savings Bank of Kentucky (the “Bank”), the indirect wholly-owned bank subsidiary of Kentucky First Federal Bancorp (the “Company”), published notification that the OCC has terminated its formal written agreement, dated August 13, 2024 (the “Agreement”), with the Bank.”

Rivulet Entertainment, Inc. amended Purchase Agreement with Rivulet Media, Inc. valued at from $3,500,000 to 12,900,000 restricted shares of common stock and 1,000,000 shares of Series C Pre (effective 2026-02-12).

“On February 12, 2026 Rivulet Entertainment, Inc., (f/k/a Advanced Voice Recognition Systems, Inc.) a Nevada corporation (“the Company”), and Rivulet Media, Inc., a Delaware corporation (Rivulet), collectively the Parties, entered into an addendum that amended the Asset Purchase Agreement (the “Purchase Agreement”), dated March 1, 2024 to reduce the cash portion of the purchase price from $3,500,000 to 12,900,000 restricted shares of common stock and 1,000,000 shares of Series C Preferred shares of the Buyer in lieu of the above stated cash amount of $3,500,000.”

Energy Services of America CORP entered into Underwriting Agreement with Lake Street Capital Markets, LLC valued at approximately $18.4 million (effective 2026-02-18).

“On February 18, 2026, Energy Services of America Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC (the “Underwriter”).”

Sow Good Inc. amended Securities Purchase Agreement with David Lazar (effective 2026-02-18).

“On February 18, 2026, Sow Good Inc. (the “ Company ”) amended the previously disclosed Securities Purchase Agreement (the “ Amendment ”) by and between the Corporation and David Lazar (the “ Purchaser ”)”

Processa Pharmaceuticals, Inc. terminated Binding Term Sheet with Intact Therapeutics valued at Term Sheet expired without execution of definitive license agreement (effective 2026-02-12).

“On February 12, 2026, Processa Pharmaceuticals, Inc.’s (the “Company”) Binding Term Sheet dated June 17, 2025 (the “Term Sheet”) with Intact Therapeutics regarding PCS12852 expired without the execution of a definitive license agreement and without the entry into the related proposed amendment to the License Agreement with Yuhan Corporation.”

Gold.com, Inc. amended Incremental Facility Agreement and First Amendment to Amended and Restated Credit Agreement with CIBC Bank USA (effective 2026-02-13).

“On February 13, 2026, Gold.com, Inc. (the "Company") entered into the Incremental Facility Agreement and First Amendment to Amended and Restated Credit Agreement (the "Credit Agreement First Amendment") with the other loan parties thereto, the lenders party thereto and CIBC Bank USA as administrative agent for the lenders.”

Lifeward Ltd. entered into Subsequent Secured Promissory Note with Oramed Pharmaceuticals, Inc. valued at initial principal amount of $525,000, which amount may be increased by up to an additional $975,000 (effective 2026-02-12).

“On February 12, 2026, the Company entered into a Secured Promissory Note (the “Subsequent Secured Promissory Note”) with Oramed Pharmaceuticals, Inc. (“Oramed”) pursuant to which the Company issued to Oramed a secured promissory note in the initial principal amount of $525,000, which amount may be increased by up to an additional $975,000 upon the mutual consent of the parties.”

Performance Food Group Co entered into Indenture with U.S. Bank Trust Company, National Association valued at $1.06 billion aggregate principal amount (effective 2026-02-19).

“issued and sold $1.06 billion aggregate principal amount of its 5.625% Senior Notes due 2034 (the “ Notes ”), which mature on March 1, 2034, pursuant to an indenture, dated as of February 19, 2026 (the “ Indenture ”), among the Issuer, PFGC, Inc., a Delaware corporation and the Issuer’s direct parent company (“ Parent ”), the other guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee.”

PULSE BIOSCIENCES, INC. terminated Prior Distribution Agreement with the sales agents named therein valued at up to $59,976,196 (effective 2026-02-18).

“Prior to the Company’s entry into the Sales Agreement, on February 18, 2026, the Company terminated its at-the-market offering program in accordance with the terms of its prior equity distribution agreement, dated as of July 15, 2024 (the “Prior Distribution Agreement”), between the Company and the sales agents named therein.”

PULSE BIOSCIENCES, INC. entered into Sales Agreement with TD Securities (USA) LLC valued at up to $59,976,196 (effective 2026-02-19).

“On February 19, 2026, Pulse Biosciences, Inc. (the “Company”) entered into an equity distribution agreement (the “Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen”) as sales agent, pursuant to which the Company may offer and sell, from time to time, through TD Cowen shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $59,976,196 (the “Shares”).”

Avalon GloboCare Corp. amended Amendment #2 (effective 2026-02-15).

“On February 15, 2026, the Company entered into Amendment #2 (the “Note Amendment”) to unsecured bridge note dated December 11, 2025 in the original principal amount of $375,000 (the “Note”).”

Avalon GloboCare Corp. amended Amended and Restated Membership Interest Purchase Agreement with Wenzhao Lu valued at amended aggregated purchase price of $9,000,000 (effective 2026-02-18).

“On February 18, 2026, the Company and the Purchaser entered into an Amended and Restated Membership Interest Purchase Agreement (the “Amended MIPA”), pursuant to which the Company sold to the Purchaser 100% of the membership interests of Avalon RT9 for (i) the Cash Consideration and (ii) the satisfaction, in full, of an approximately $5,900,000 balance due on an existing mortgage financing.”

AMERICAN REBEL HOLDINGS INC entered into Exchange Agreement with Streeterville Capital, LLC valued at $130,000 (effective 2026-02-18).

“reviously disclosed, on June 26, 2025, the Company entered into a note purchase agreement with Streeterville Capital, LLC (“Streeterville”) pursuant to which the Company issued and sold to Streeterville a secured promissory note in the original principal amount of $5,470,000.”

ADDENTAX GROUP CORP. entered into Agreement with Guang Wen Global Limited valued at approximately $5.5 million (effective 2026-02-17).

“On February 17, 2026, Addentax Group Corp. (the “Company”), through itself or its designated entity (the “Buyer”), entered into a stock purchase agreement (the “Agreement”) to acquire 34,200,000 shares of Common Shares, par value $0.001 per share (the “Shares”), in Keemo Fashion Group Limited’s (“Keemo Fashion”), a Nevada corporation, with the Guang Wen Global Limited (the “Seller”).”

Sports Entertainment Gaming Global Corp entered into Common Stock Equity Distribution Agreement with Dawson James Securities, Inc. valued at up to $5,572,584 (effective 2026-02-18).

“On February 18, 2026, Sports Entertainment Gaming Global Corporation (the “Company”) entered into a Common Stock Equity Distribution Agreement (the “Agreement”) with Dawson James Securities, Inc. (the “Sales Agent”).”

Hims & Hers Health, Inc. entered into Securities Sale Deed with the sellers party thereto valued at up to approximately $1,150,000,000 (effective 2026-02-19).

“On February 19, 2026, Hims & Hers Health, Inc. (the “ Company ”), Hims, Inc. (the “ Guarantor ”), and Horizon BidCo Pty Ltd ACN 694 778 375, an Australian proprietary company (the “ Purchaser ”) and wholly-owned subsidiary of the Company, entered into a Securities Sale Deed (the “ Deed ”) with the sellers party thereto (the “ Sellers ”), pursuant to which, among other things, the Sellers agreed to sell and Purchaser agreed to purchase from each Seller (the “ Proposed Acquisition ”) all of the issued capital (the “ Target Equity ”) of EUC Management Pty Ltd ACN 631 013 860 (d/b/a Eucalyptus) (the “ Target ”).”

COMPASS Pathways plc entered into Underwriting Agreement with Jefferies LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., and Stifel, Nicolaus & Company, Incorporated, as representatives valued at $150.0 million (effective 2026-02-18).

“On February 18, 2026, Compass Pathways plc (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, TD Securities (USA) LLC, Cantor Fitzgerald & Co., and Stifel, Nicolaus & Company, Incorporated, as representatives (the “Representatives”) of the underwriters listed therein (the “Underwriters”), relating to the issuance and sale in an underwritten public offering (the “Offering”) of (i) 17,500,000 American Depositary Shares, each representing one ordinary share, nominal value £0.008 each, of the Company (the “ADSs”) at a public offering price of $8.00 per ADS, and (ii) in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs (the “Pre-Funded Warrants”) at a public offering price of $7.999 per Pre-Funded Warrant.”

HCW Biologics Inc. entered into Existing Warrants Amendment Agreement with the Purchaser (effective 2026-02-17).

“On February 17, 2026, the Company also entered into a privately negotiated agreement with the Purchaser, which holds certain existing outstanding warrants to purchase up to 3,020,410 shares of Common Stock (the “Prior Warrants”) to seek stockholder approval in accordance with applicable Nasdaq rules to reduce the exercise price of such Prior Warrants to the public offering price per Unit paid in the Offering (the “Existing Warrants Amendment Agreement”).”

HCW Biologics Inc. entered into Placement Agency Agreement with Maxim Group LLC (effective 2026-02-17).

“On February 17, 2026, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (“Maxim” or the “Placement Agent”) pursuant to which the Company engaged the Placement Agent as the exclusive placement agent in connection with the Offering.”

HCW Biologics Inc. entered into Securities Purchase Agreement with a single institutional investor valued at approximately $1.5 million (effective 2026-02-17).

“On February 17, 2026, HCW Biologics Inc. (the “Company”) entered into a securities purchase agreement (“SPA”) with a single institutional investor (the "Purchaser") pursuant to which the Company agreed to offer and sell, in a follow-on public offering (the “Offering”), 2,477,292 units”

Core Scientific, Inc./tx entered into Cooperation Agreement with Two Seas Capital LP (effective 2026-02-18).

“On February 18, 2026, Core Scientific, Inc., a Delaware corporation (the “Company”) entered into a cooperation agreement (the “Cooperation Agreement”) with Two Seas Capital LP (“Two Seas”).”

Candel Therapeutics, Inc. entered into Purchase Agreement with funds managed by RTW Investments, LP valued at $100 million (effective 2026-02-19).

“On February 19, 2026, Candel Therapeutics, Inc. (the “Company”) announced its entry into a purchase and sale agreement (the “Purchase Agreement”) with funds managed by RTW Investments, LP (the “Purchaser”). Under the terms of the Purchase Agreement, the Purchaser has agreed to pay the Company $100 million”

VSEE HEALTH, INC. entered into Stock Purchase Agreement with Go Biz Holdings, LLC valued at Company agreed to purchase $2.0 million of shares of GMRx common stock, representing a ten percent o (effective 2026-01-16).

“On January 16, 2026, the Company entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GMRx and Go Biz Holdings, LLC, a Wyoming limited liability company (“GBiz”), pursuant to which the Company agreed to purchase from GBiz $2.0 million of shares of GMRx’s common stock (the “Shares”) in a private transaction pursuant to the exemptions from registration provided in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Rule 506 of Regulation D promulgated thereunder, representing a ten percent (10%) ownership interest in GMRx.”

VSEE HEALTH, INC. entered into Managed Services Agreement with GoMyRx, Inc. valued at Company provides platform administration, customer/user support, third-party vendor coordination, an (effective 2025-12-26).

“On December 26, 2025, VSee Health, Inc., a Delaware Corporation (the “Company”) and iDoc Virtual Telehealth Solutions, Inc., a Texas Corporation and wholly-owned subsidiary of the Company, entered into a Managed Services Agreement with GoMyRx, Inc., a Wyoming corporation (“GMRx”), a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem (the “MSA”).”

Orion Properties Inc. entered into Credit Agreement for New Revolving Facility with Wells Fargo Bank, National Association, as Administrative Agent valued at $215.0 million senior secured revolving credit facility (effective 2026-02-18).

“On February 18, 2026, the Company, as parent, and Orion Properties LP, as borrower (“Orion OP”), entered into a credit agreement for a new $215.0 million senior secured revolving credit facility (the “New Revolving Facility”), with the financial institutions party thereto, as lenders, and Wells Fargo Bank, National Association, as Administrative Agent.”

Orion Properties Inc. entered into Loan Modification Agreement with Computershare Trust Company, National Association, as Trustee valued at $355.0 million fixed rate securitized mortgage loan (effective 2026-02-17).

“On February 17, 2026, Orion Properties Inc. (the “Company”), through certain of its subsidiaries (the “Mortgage Borrowers”), entered into a loan extension and modification agreement (“Loan Modification Agreement”) with Computershare Trust Company, National Association, as Trustee, for the benefit of the holders of Wells Fargo Commercial Mortgage Trust 2022-ONL, Commercial Mortgage Pass-Through Certificates, Series 2022-ONL (the "Lender").”

KKR FS Income Trust Select entered into Loan and Security Agreement with Bank of Montreal (BMO), as administrative agent, and the lenders party thereto valued at up to $400,000,000 (effective 2026-02-13).

“On February 13, 2026, K-FITS Finance Mount Royal LLC ("Mount Royal"), a wholly-owned, special purpose financing subsidiary of KKR FS Income Trust Select (the "Company"), entered into a Loan and Security Agreement (the "Loan Agreement"), by and among Mount Royal, as borrower, the Company, as equityholder and as collateral manager, Bank of Montreal ("BMO"), as administrative agent, BMO Bank N.A. and the other lenders from time to time party thereto, and Western Alliance Trust Company, N.A., as collateral custodian.”

Black Hawk Acquisition Corp entered into Note with Black Hawk Management LLC valued at principal amount of up to $300,000 (effective 2026-02-12).

“On February 12, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the “Sponsor”).”

FirstEnergy Transmission, LLC amended Grid Growth Operating Agreement with Transource Energy, LLC (effective 2026-02-13).

“On February 13, 2026, FirstEnergy Transmission, LLC (“FET”) and Transource Energy, LLC, a subsidiary of American Electric Power Company, Inc. (“Transource”), entered into the Grid Growth Ventures, LLC (“Grid Growth”) Amended and Restated Operating Agreement (“Grid Growth Operating Agreement”), which amended and restated a provisional operating agreement between the Grid Growth members entered into in December 2025.”

SharonAI Holdings Inc. entered into Underwriting Agreement with Lucid Capital Markets, LLC (effective 2026-02-18).

“On February 18, 2026, SharonAI Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lucid Capital Markets, LLC as representative of the several underwriters identified therein (the “Underwriters”), relating to the public offering (the “Offering”) of 4,166,666 shares (the “Firm Shares”) of the Company’s Class A Ordinary Common Stock, par value $0.0001 (the “Common Stock”), at public offering price of $30.00 per share.”

Park Dental Partners, Inc. amended Amendment with U.S. Bank National Association (effective 2026-01-01).

“On February 13, 2026 (with an effective date of January 1, 2026), Park Dental Partners, Inc. (the “Company”), together with PDG, P.A., Dental Specialists of Minnesota, PLLC, Orthodontic Specialists of Minnesota, PLLC, The Facial Pain Center, PLLC, and PDP MN, LLC (collectively with the Company, the “Borrowers”), entered into an Amendment Agreement (the “Amendment”) with U.S. Bank National Association (the “Lender”) to amend that certain Amended and Restated Credit Agreement, dated as of March 27, 2024 (as amended, the “Credit Agreement”).”

Cardinal Infrastructure Group Inc. entered into Purchase Agreement with Diamond Interests Group, LLC (the "Seller") valued at aggregate consideration of $245.5 million (effective 2026-02-18).

“On February 18, 2026, Cardinal Infrastructure Group Inc. (the “Company,” “Cardinal,” “we”, “us”, or “our”) and Cardinal Civil Contracting Holdings LLC, a controlled subsidiary of the Company (“Purchaser”), completed (the “Closing”) the acquisition (the “Acquisition”) of all of the equity interests in A.L. Grading Contractors, LLC (“ALGC”) pursuant to a membership interests purchase and contribution agreement (the “Purchase Agreement”), dated February 18, 2026, with Diamond Interests Group, LLC (the “Seller”), ALGC, Anthony L. Wood, Jr. (“Anthony Wood”) and Benjamin A. Wood (“Benjamin Wood” and, together with Anthony Wood, the “Seller Owners”).”

Willow Lane Acquisition Corp. II entered into Indemnity Agreement with each director and officer of the Company valued at Indemnity Agreement dated February 12, 2026, by and among the Company and each director and officer (effective 2026-02-12).

“An Indemnity Agreement, dated February 12, 2026 (the “ Indemnity Agreement ”), by and among the Company and each director and officer of the Company, a copy of the form of which is attached as Exhibit 10.7 hereto”

Willow Lane Acquisition Corp. II entered into Administrative Services Agreement with Willow 2 Office LLC valued at Administrative Services Agreement dated February 12, 2026, by and between the Company and Willow 2 O (effective 2026-02-12).

“An Administrative Services Agreement, dated February 12, 2026, by and between the Company and Willow 2 Office LLC, a copy of which is attached as Exhibit 10.6 hereto”